Effects of Omega-3 Fatty Acids in Ambient Air Pollution Exposure in Healthy Adults
PISCES
1 other identifier
observational
62
1 country
1
Brief Summary
This observational study recruits healthy individuals who have been routinely taking high amount (at least 3 g/wk) of dietary eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), and those who don't, and examines the efficacy of dietary EPA and DHA in ameliorating the cardiopulmonary effects of exposure to ambient air pollution.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Sep 2016
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 15, 2016
CompletedFirst Submitted
Initial submission to the registry
September 28, 2016
CompletedFirst Posted
Study publicly available on registry
September 30, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 15, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
November 15, 2019
CompletedMay 10, 2022
May 1, 2022
3.2 years
September 28, 2016
May 8, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
heart rate variability
Sep. 2016 to Sep 2019
Secondary Outcomes (4)
endothelial cell function
Sep. 2016 to Sep 2019
diameters of retinal arteries and veins
Sep. 2016 to Sep 2019
pulmonary function indices
Sep. 2016 to Sep 2019
blood biomarkers
Sep. 2016 to Sep 2019
Study Arms (2)
omega-3
individuals voluntarily taking at least 3 g/wk of EPA and DHA from dietary sources including fish oil supplements and ocean fish/shellfish consumption for a period of at least 6 months prior to enrollment in the study
control
individuals who have consumed no more than 1 serving size (4-6 oz)/month of ocean fish/shellfish, or no more than 1 pill/month of fish oil supplement during the 6 month period preceding enrollment
Interventions
Eligibility Criteria
Healthy 35-55 year-old male and female subjects
You may qualify if:
- Aged 25-55 years old healthy male and female (19≤BMI≤30).
- Normal resting ECG. No history of heart arrhythmia.
- Oxygen saturation greater than 96% at the time of physical exam.
- Taking at least 3 grams of EPA and DHA from dietary sources including fish oil supplements and ocean fish/shellfish for a 6 months or longer period of time preceding enrollment in the study; or taking no more than 1 serving size (4-6 oz)/month of ocean fish/shellfish, or no more than 1 pill/month of fish oil supplement during the previous 6 months or longer period of time.
You may not qualify if:
- Individuals with a history of acute or chronic cardiovascular disease, such as myocardial infarction.
- Individuals with a history of chronic respiratory disease, such as COPD and asthma.
- Individuals with a history of cancer (possible exception for history of non-melanoma skin cancer).
- Uncontrolled hypertension (≥150 systolic, ≥90 diastolic).
- Individuals who are diabetic (previously diagnosed or with hemoglobin A1c level \>6.4%).
- Individuals who are currently smoking (including vaping, or using hookah or e cigarettes) or have a smoking history within 1 year of study (defined as more than 1 pk/yr in the past year) or have a greater than/equal to a 5 pack year smoking history.
- Individuals living with a smoker who smokes inside the house.
- Individuals who are regularly exposed to high levels of vapors, dust, gases, or fumes.
- Individuals who do not understand or speak English.
- Individuals who are taking b-blocker medications.
- Individuals who are taking statins.
- Individuals that are unwilling or unable to maintain their current dietary pattern for the whole study.
- Individuals with bleeding or clotting disorders.
- Individuals who have active allergies.
- Individuals who have an allergy to latex, or skin allergy to tape or electrodes.
- +4 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
EPA Human Studies Facility
Chapel Hill, North Carolina, 27514, United States
Related Publications (3)
Chen H, Zhang S, Shen W, Salazar C, Schneider A, Wyatt LH, Rappold AG, Diaz-Sanchez D, Devlin RB, Samet JM, Tong H. Omega-3 fatty acids attenuate cardiovascular effects of short-term exposure to ambient air pollution. Part Fibre Toxicol. 2022 Feb 9;19(1):12. doi: 10.1186/s12989-022-00451-4.
PMID: 35139860DERIVEDChen H, Zhang S, Shen W, Salazar C, Schneider A, Wyatt L, Rappold AG, Diaz-Sanchez D, Devlin RB, Samet JM, Tong H. The influence of dietary intake of omega-3 polyunsaturated fatty acids on the association between short-term exposure to ambient nitrogen dioxide and respiratory and cardiovascular outcomes among healthy adults. Environ Health. 2021 Dec 7;20(1):123. doi: 10.1186/s12940-021-00809-9.
PMID: 34872587DERIVEDTong H, Zhang S, Shen W, Chen H, Salazar C, Schneider A, Rappold AG, Diaz-Sanchez D, Devlin RB, Samet JM. Lung Function and Short-Term Ambient Air Pollution Exposure: Differential Impacts of Omega-3 and Omega-6 Fatty Acids. Ann Am Thorac Soc. 2022 Apr;19(4):583-593. doi: 10.1513/AnnalsATS.202107-767OC.
PMID: 34797737DERIVED
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- FED
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Research biologist
Study Record Dates
First Submitted
September 28, 2016
First Posted
September 30, 2016
Study Start
September 15, 2016
Primary Completion
November 15, 2019
Study Completion
November 15, 2019
Last Updated
May 10, 2022
Record last verified: 2022-05